About 7 million adults in the U.S. whose immune systems are so vulnerable they might benefit from a new COVID-19 drug, but supply is currently low. (Feb. 10)
Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Instagram: https://www.instagram.com/APNews/
You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/a158b1330a28480382827706137a0989